Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0036341 (schizophrenia)
60,220 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

An autopsy case of a 65-year-old female with dentatorubropallidoluysian atrophy (DRPLA) is reported. Her mother had gait disturbance and died at the age of 63. Her mother's brother developed psychotic symptoms. A daughter of her older sister was observed to have involuntary movement when she admitted to a mental hospital due to post-delivery psychotic state. Her younger brother has developed gait disturbance from about 56-year-old. Her older son has suffered from schizophrenia for long years. Since 58-year-old, she developed cerebellar ataxic gait and three years later, choreic involuntary movement developed in her extremities and face and progressively became prominent. Since 63-year-old, abnormal behavior brought about by the visual hallucination was occasionally observed. At the age of 63, she admitted to a mental hospital because of persistent persecutive delusion for her husband and was clinically diagnosed as Huntington's chorea for her remarkable choreic movement and psychotic state with dementia. Hypertension was also noticed. At the age of 65, she died of acute pneumonia. The duration of her illness was about 6 years. Histopathological findings of the CNS: the brain weighed 1,014 g. Brainstem and spinal cord were noticed to be relatively small in size. The cerebral cortex was well preserved. The cerebral white matter was diffusely demyelinated in the central semiovale where arteriosclerotic change of the small vessels was remarkable. Significant pathological changes consisted of marked symmetrical atrophy of the following two systems, i. e., dentatofugal pallidoluysian systems.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:[An autopsy case of dentatorubropallidoluysian atrophy (DRPLA) clinically diagnosed as Huntington's chorea]. 293 81

The case notes of 1069 children and teenagers admitted to Bethlem Royal Hospital, ("Bedlam"), in the nineteenth century were analysed with particular reference to the frequencies and types of hallucinations. There was a significant increase (P less than 0.001) in the frequencies of auditory and visual hallucination from 1830 to the end of the century. The presence of auditory hallucinations of people, when they occurred in males, significantly worsened the prognosis (P less than 0.025) compared to females. The findings are considered with special reference to the incidence and aetiology of schizophrenia in the last century.
...
PMID:Hallucinations in children and teenagers admitted to Bethlem Royal Hospital in the nineteenth century and their possible relevance to the incidence of schizophrenia. 330 35

Of 104 patients treated in a psychiatric hospital because of mental disturbances caused by an infection, almost one-half had been referred directly to the psychiatric hospital on account of their psychically abnormal behaviour. The infectious disease causing these disturbances was diagnosed only after their admission. In most of the cases the psychic abnormalities did not seem to be due to a physical cause, so that the somatic examination was frequently delayed. Pneumonic infections were most frequently seen, but there were also numerous other infections from all other disciplines of medicine. Clouding of consciousness developed rapidly in 84% of the patients during the course of inpatient treatment with an incidence that was almost fivefold that of the initial stage. Visual hallucinations (37%) were the most frequent productive-psychotic phenomenon. 45% of the patients presented with a delirious pattern and 4% with a psychosis resembling schizophrenia. In 35% of the patients treatment with psychotropic drugs proved necessary, whereas with the remaining 65% therapy remained antibiotic or generally somatic only. 18% of the patients died.
...
PMID:[Infection-caused mental disorders. Are they still topical in the antibiotic era?]. 356 70

A patient with chronic schizophrenia who had visual hallucinations of lilliputian nature is described. The authors review the studies on prevalence of visual hallucinations in schizophrenic patients and suggest that visual hallucinations may be more common in schizophrenia than previously acknowledged. The authors suggest a routine enquiry about visual hallucination in clinical practice and emphasize the need for further research under controlled conditions.
...
PMID:Lilliputian hallucinations in schizophrenia: case report and review of literature. 871 Oct 73

Visual hallucinations, without auditory hallucinations and in the elderly, are not usually based on previous psychiatric illness. The elderly can, of course, hallucinate as part of severe depression or a life-long schizophrenia, but the clinician should assume that there is an organic basis when an elderly individual begins to develop visual hallucinations for the first time. Representative cases that illustrate visual hallucinations due to ophthalmological, vascular, or degenerative processes are presented. Visual hallucinations can be linked to disorders in multiple parts of the nervous system. Even when related to medications, dementia may also be contributory, as is illustrated by the hallucinations seen in those with Parkinson's disease. Treatment of visual hallucinations is treatment of the underlying cause although some newer drugs such as clozapine may also be helpful for selected patients.
...
PMID:Visual hallucinations in the elderly. 930 14

Visual hallucinations occur in a wide variety of neurological and psychiatric disorders, including toxic disturbances, drug withdrawal syndromes, focal central nervous system lesions, migraine headaches, blindness, schizophrenia, and psychotic mood disorders. Visual hallucinations are generally assumed to characteristically reflect organic disorders and are very rare in affective disorders. Here, we present a case of visual hallucinations in a young female with bipolar illness during the manic phase.
...
PMID:Visual hallucinations in mania. 2202 57

Numerous studies have found that hallucinatory experiences occur in the general population. But to date, few studies have been conducted to compare clinical and nonclinical groups across a broad array of clinical symptoms that may co-occur with hallucinations. Likewise, hallucination-like experiences are measured as a multidimensional construct, with clinical and subclinical components related to vivid daydreams, intrusive thoughts, perceptual disturbance, and clinical hallucinatory experiences. Nevertheless, these individual subcomponents have not been examined across a broad spectrum of clinically disordered and nonclinical groups. The goal of the present study was to analyze the differences and similarities in the distribution of responses to hallucination-like experience in clinical and nonclinical populations and to determine the relation of these hallucination-like experiences with various clinical symptoms. These groups included patients with schizophrenia, non-psychotic clinically disordered patients, and a group of individuals with no psychiatric diagnoses. The results revealed that hallucination-like experiences are related to various clinical symptoms across diverse groups of individuals. Regression analysis found that the Psychoticism dimension of the Symptom Check List (SCL-90-R) was the most important predictor of hallucination-like experiences. Additionally, increased auditory and visual hallucination was the only subcomponent that differentiated schizophrenic patients from other groups. This distribution of responses in the dimensions of hallucination-like experiences suggests that not all the dimensions are characteristic of people hearing voices. Vivid daydreams, intrusive thoughts, and auditory distortions and visual perceptual distortions may represent a state of general vulnerability that does not denote a specific risk for clinical hallucinations. Overall, these results support the notion that hallucination-like experiences are closer to a quasi-continuum approach and that total scores on these scales explain a state of vulnerability to general perceptual disturbance.
...
PMID:Analysis of the multidimensionality of hallucination-like experiences in clinical and nonclinical Spanish samples and their relation to clinical symptoms: implications for the model of continuity. 2204 32

It has been suggested that certain types of auditory hallucinations may be the by-product of a perceptual system that has evolved to be oversensitive to threat-related stimuli. People with schizophrenia and high schizotypes experience visual as well as auditory hallucinations, and have deficits in processing facial emotions. We sought to determine the relationship between visual hallucination proneness and the tendency to misattribute threat and non-threat related emotions to neutral faces. Participants completed a questionnaire assessing visual hallucination proneness (the Revised Visual Hallucination Scale - RVHS). High scoring individuals (N=64) were compared to low scoring individuals (N=72) on a novel emotion detection task. The high RVHS group made more false positive errors (ascribing emotions to neutral faces) than the low RVHS group, particularly when detecting threat-related emotions. All participants made more false positives when neutral faces were presented to the right visual field than to the left visual field. Our results support continuum models of visual hallucinatory experience in which tolerance for false positives is highest for potentially threatening emotional stimuli and suggest that lateral asymmetries in face processing extend to the misperception of facial emotion.
...
PMID:Misperceiving facial affect: effects of laterality and individual differences in susceptibility to visual hallucinations. 2238 49

Schizophrenia and various neurological disorders have some signs and symptoms. Visual hallucinations are one of such disorders. The related studies in some diseases for example Parkinson Disease and Lewy Body Dementia indicate that Acetylcholine (Ach) plays a significant role in neuropsychiatric manifestation and its association with visual hallucination; therefore, visual hallucinations occur due to the depletion of Ach. Drug therapies such as Cholinesterase inhibitors (ChEIs) for increasing Ach level may be beneficial in treating visual hallucination. AchEI's have been used in the treatment of visual hallucinations in Dementia and Parkinson's Disease. We thought that a similar Ach depletion may cause visual hallucinations in patients with schizophrenia and may provide a target for drug treatment. We had a patient with schizophrenia whose psychotic symptoms responded to the treatment plan, but her visual hallucination did not. However, the patient's visual hallucination successfully responded to Rivastigmine (AchEI).This case illustrates the use of an AchEI in the treatment of refractory visual hallucinations in a patient with schizophrenia.
...
PMID:Treatment of Visual Hallucinations in Schizophrenia by Acetylcholinesterase Inhibitors: a case report. 2295 43

A 13-year-old boy suffered from hypersomnia, fragmented nighttime sleep, and cataplexy since age 10 years, and then developed prominent psychotic symptoms (i.e., auditory and visual hallucination, hallucinatory behavior, delusions of reference, and misidentification) that occurred persistently during the wakeful and consciously clear period when he was aged 12 years. The child underwent additional medical evaluation and testing, and comorbidity of narcolepsy and schizophrenia was diagnosed. The child's psychotic symptoms and narcolepsy improved significantly upon treatment with methylphenidate 30 mg, olanzapine 25 mg, and haloperidol 10 mg. In this case, the child's symptomology of narcolepsy and schizophrenia and the dilemma of the use of antipsychotics and psychostimulants are representative examples of the diagnostic and therapeutic challenges in adolescent psychiatry.
...
PMID:Comorbidity of narcolepsy and schizophrenia in an adolescent patient. 2510 99


1 2 Next >>